Stockscreener 앱 받기
43.56
0.28%
0.12
시장 영업 전:
44.43
0.87
+2.00%
Omnicell Inc 주식(OMCL)의 최신 뉴스
Omnicell (OMCL) Is Up 13.7% After Earnings Beat, Raised Guidance, And Key Pharmacy HireWhat's Changed - Sahm
Omnicell (OMCL) is a Great Momentum Stock: Should You Buy? - Yahoo Finance
North America Central Fill Pharmacy Automation Market Growth - openPR.com
Zacks Industry Outlook Highlights Veeva Systems, Doximity and Omnicell - TradingView
Surging earnings estimates signal upside for Omnicell (OMCL) stock - MSN
The 5 Most Interesting Analyst Questions From Omnicell’s Q1 Earnings Call - TradingView
Omnicell to Present at the BofA Securities 2026 Healthcare Conference - BioSpace
Omnicell gets relative strength rating upgrade - MSN
Omnicell's May 12 healthcare conference presentation will stream live - Stock Titan
Surging Earnings Estimates Signal Upside for Omnicell (OMCL) Stock - Yahoo Finance
Wall Street Analysts See a 41.19% Upside in Omnicell (OMCL): Can the Stock Really Move This High? - Yahoo Finance
Discipline and Rules-Based Execution in OMCL Response - Stock Traders Daily
Assessing Omnicell (OMCL) Valuation After Q1 Earnings Beat And Higher EPS Guidance - Yahoo Finance
Omnicell (OMCL) Q1 2026 Earnings Transcript - AOL.com
Omnicell Stock Soars 20.94%, Hits Intraday High of $46.85 - Markets Mojo
Omnicell (NASDAQ:OMCL) Raised to Buy at Wall Street Zen - MarketBeat
Omnicell OMCL Q2 2025 Earnings Transcript - AOL.com
A Look at Omnicell Inc (OMCL) After 3.3% Gain -- GF Value $38.55 vs Price $42.80 - GuruFocus
Omnicell (OMCL) Q1 2025 Earnings Transcript - AOL.com
Here's why Omnicell (OMCL) is a strong value stock - MSN
Omnicell Q1 Earnings & Revenues Top, Stock Up, Gross Margin Rises - Yahoo! Finance Canada
Vanguard holds 2.27M shares in Omnicell (NASDAQ: OMCL) - Stock Titan
Analysts Offer Insights on Healthcare Companies: Omnicell (OMCL), Rocket Pharmaceuticals (RCKT) and Cullinan Management (CGEM) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Omnicell (OMCL) and Shattuck Labs (STTK) - The Globe and Mail
Omnicell Reports Strong Q1 2026 Earnings, Raises Full-Year GuidanceNews and Statistics - IndexBox
Omnicell (OMCL) Q1 EPS Recovery Tests Bullish Margin Improvement Narrative - simplywall.st
Omnicell Earnings Call Shows Profits Surging, Outlook Raised - The Globe and Mail
Omnicell (NASDAQ:OMCL) Shares Down 7.4%Here's Why - MarketBeat
Vanguard (NASDAQ: OMCL) owns 3.24M Omnicell shares, 7.13% stake - Stock Titan
Omnicell appoints Rick Couldry as SVP, chief pharmacy and clinical officer - TipRanks
Omnicell welcomes hospital pharmacy leader Rick Couldry as senior vice president - marketscreener.com
Analyst Reiterates Buy on Omnicell, Citing Once-in-a-Decade Product Cycle Momentum and Margin Strength; Price Target Maintained at $70 - TipRanks
Omnicell Welcomes Hospital Pharmacy Leader Rick Couldry as Senior Vice President, Chief Pharmacy and Clinical Officer - BioSpace
Omnicell names Rick Couldry as senior vice president, chief pharmacy and clinical officer - Fort Worth Report
Investment Advisor Sells $6.6 Million Worth of Medical Solutions Stock, According to Recent SEC Filing - The Globe and Mail
OMCL Maintained by Keybanc -- Price Target Raised to $70 - GuruFocus
Omnicell Names Rick Couldry Chief Pharmacy and Clinical Officer - Fort Worth Inc.
KeyBanc raises Omnicell stock price target to $70 on growth outlook By Investing.com - Investing.com South Africa
KeyBanc raises Omnicell stock price target to $70 on growth outlook - Investing.com Australia
Omnicell, Inc. (NASDAQ:OMCL) Q1 2026 Earnings Call Transcript - Insider Monkey
Omnicell Welcomes Hospital Pharmacy Leader Rick Couldry As Senior Vice President - TradingView
Omnicell Q1 2026 earnings preview - MSN
TX-OMNICELL-INC. - Black Hills Pioneer
Omnicell, Inc. Appoints Rick Couldry as Senior Vice President, Chief Pharmacy and Clinical Officer - marketscreener.com
OMCL Q1 Deep Dive: Platform Expansion and Cost Controls Drive Margin Turnaround - StockStory
Omnicell Inc (OMCL) Q1 2026 Earnings Call Highlights: Strong Rev - GuruFocus
Omnicell Welcomes Hospital Pharmacy Leader Rick Couldry as Senio - GuruFocus
Omnicell to Release First Quarter 2026 Financial Results on April 28, 2026 - Quantisnow
Omnicell Q1 Non-GAAP Earnings, Revenue Rise; 2026 Non-GAAP Earnings Outlook Lifted - Moomoo
Omnicell Stock Jumps 21% In A Day, Now Is Not The Time To Buy The Stock - Trefis
Why Omnicell stock trounced the market on Tuesday - MSN
Why Omnicell Stock Trounced the Market on Tuesday - The Motley Fool
Piper Sandler raises Omnicell stock price target on earnings beat By Investing.com - Investing.com Nigeria
Omnicell Q1 2026 Earnings Call Transcript - MarketBeat
A Look at Omnicell Inc (OMCL) After 20.9% Gain -- GF Value $38.0 - GuruFocus
Is It Too Late To Consider Omnicell (OMCL) After Its Recent 45% One Year Surge - simplywall.st
1.66%
1.60%
자본화:
|
볼륨(24시간):